Using CRISPR to investigate pancreatic cancer | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« Cleaning Up Ancient Human DNA

We Celebrate Our Top Authors: 4/2012 to 7/2015 @Leaders in Pharmaceutical Business Intelligence and Our e-Books on Amazon.com »

Using CRISPR to investigate pancreatic cancer

July 31, 2015 by 2012pharmaceutical

Writing about pancreatic cancer always gives me a pang. My grandmother died from the disease over 30 years ago, but I still remember the anguish of her diagnosis and the years of chemotherapy and surgery she endured before her death. This disease is much more personal to me than many I cover.

Sourced through Scoop.it from: scopeblog.stanford.edu

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Advertisements

Posted in Uncategorized | Leave a Comment

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google+ account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: